Citation

Naud S, Westwood IM, Faisal A, Sheldrake P, Bavetsias V, Atrash B, Cheung KM, Liu M, Hayes A, Schmitt J, Wood A, Choi V, Boxall K, Mak G, Gurden M, Valenti M, de Haven Brandon A, Henley A, Baker R, McAndrew C, Matijssen B, Burke R, Hoelder S, Eccles SA, Raynaud FI, Linardopoulos S, van Montfort RL, Blagg J.: Structure-based design of orally bioavailable 1H-pyrrolo[3,2-c]pyridine inhibitors of mitotic kinase monopolar spindle 1 (MPS1). J Med Chem, Volume 56 (24), 2013

Authors

Atrash B, Baker R, Bavetsias V, Blagg J., Boxall K, Burke R, Cheung KM, Choi V, de Haven Brandon A, Eccles SA, Faisal A, Gurden M, Hayes A, Henley A, Hoelder S, Linardopoulos S, Liu M, Mak G, Matijssen B, McAndrew C, Naud S, Raynaud FI, Schmitt J, Sheldrake P, Valenti M, van Montfort RL, Westwood IM, Wood A

Journal

J Med Chem

Year

2013

DOI

10.1021/jm401395s

PubMed

24256217

Machine-readable

REST APIRDF